These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8061849)

  • 21. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors.
    Franz IW; Tönnesmann U; Müller JF
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):631-9. PubMed ID: 9657621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisinopril and diltiazem reduce left ventricular mass without changing blood pressure in normotensive subjects with exaggerated blood pressure response to exercise.
    Polónia J; Martins L; Macedo F; Faria DB; Simões L; Brandão F; Gomes MC
    Rev Port Cardiol; 1996 Mar; 15(3):185-93, 179. PubMed ID: 8634167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of spirapril on left ventricular hypertrophy due to volume overload in rats.
    Umemura K; Zierhut W; Rudin M; Novosel D; Robertson E; Pedersen B; Hof RP
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):375-81. PubMed ID: 1378117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
    Dahlöf B; Hansson L
    J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients.
    Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M
    Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR; García-Acuña JM; Pose A; Varela A; Calvo C; Cabezas-Cerrato J; de la Peña MG
    Am J Cardiol; 1998 Jan; 81(2):170-4. PubMed ID: 9591900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
    Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
    Dahlöf B
    Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spirapril in chronic renal failure.
    Stein G; Sierakowski B; Jansa U; Haufe CC
    Blood Press Suppl; 1994; 2():54-60. PubMed ID: 8061847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure and myocardial perfusion in hypertensive patients with and without left ventricular hypertrophy.
    Boström PA; Mansour P; Diemer H; Mattiasson I; Nehoum A; Lilja B; Berglund G
    J Hum Hypertens; 1995 Dec; 9(12):969-74. PubMed ID: 8746641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
    Skudicky D; Sareli P; Libhaber E; Candy G; Radevski I; Valtchanova Z; Tshele E; Thijs L; Wang JG; Staessen JA
    Circulation; 2002 Feb; 105(7):830-6. PubMed ID: 11854123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
    Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
    Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.